A Review of Bayesian Perspectives on Sample Size Derivation for Confirmatory Trials (Q5057002): Difference between revisions
From MaRDI portal
Created claim: Wikidata QID (P12): Q111149820, #quickstatements; #temporary_batch_1711094041063 |
ReferenceBot (talk | contribs) Changed an Item |
||
| Property / cites work | |||
| Property / cites work: Q4264744 / rank | |||
Normal rank | |||
| Property / cites work | |||
| Property / cites work: Incorporating scientific, ethical and economic considerations into the design of clinical trials in the pharmaceutical industry: a sequential approach / rank | |||
Normal rank | |||
| Property / cites work | |||
| Property / cites work: Sampling / rank | |||
Normal rank | |||
| Property / cites work | |||
| Property / cites work: Group Sequential and Confirmatory Adaptive Designs in Clinical Trials / rank | |||
Normal rank | |||
Latest revision as of 03:44, 31 July 2024
scientific article; zbMATH DE number 7632881
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A Review of Bayesian Perspectives on Sample Size Derivation for Confirmatory Trials |
scientific article; zbMATH DE number 7632881 |
Statements
A Review of Bayesian Perspectives on Sample Size Derivation for Confirmatory Trials (English)
0 references
14 December 2022
0 references
assurance
0 references
expected power
0 references
probability of success
0 references
power
0 references
sample size derivation
0 references
